Bruker Analyst Price Targets - Benzinga

Bruker Corp

BRKRNASDAQ

Trade with Public

Trade with Public

$58.84

0.921.59%

마지막 업데이트: Oct 9, 4:02 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

Bruker Analyst Price Targets - Benzinga

Bruker Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bruker (BRKR).

Price Target Range — 13 Quarters

Analyst Consensus — 13 Analysts

8Buy

4Hold

1Sell

Consensus RatingBuy# Analysts13Avg. Consensus PT$62Upside to Avg. PT+6.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$58→$70
Oct 1, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$70→$72
Sep 29, 2026	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$80
Sep 9, 2026	UBS	Dan Leonard	PT Raise	Neutral	$45→$65
Aug 5, 2026	Citigroup	Brendan Digan	PT Cut	Neutral	$60→$53
Jul 8, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$44→$60
Jul 7, 2026	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$70
Jun 29, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$50→$70
Jun 24, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$53→$60
Jun 8, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$65
Jun 2, 2026	Wolfe Research	Mike Polark	Assumes	Peer Perform	—
May 7, 2026	UBS	Dan Leonard	PT Raise	Neutral	$40→$45
May 7, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$40→$44
May 7, 2026	TD Cowen	Kyle Boucher	PT Raise	Hold	$43→$45
May 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$45→$53
Apr 15, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$50→$45
Apr 14, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$50→$45
Mar 30, 2026	Guggenheim	Subbu Nambi	PT Cut	Buy	$58→$50
Feb 13, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$53→$40
Feb 13, 2026	Goldman Sachs	Evie Koslosky	PT Cut	Sell	$40→$35

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Bruker, Raises Price Target to $72

Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $70 to $72.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $80

Leerink Partners analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $60 to $80.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Bruker, Raises Price Target to $65

UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $45 to $65.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Bruker, Lowers Price Target to $53

Citigroup analyst Brendan Digan maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $60 to $53.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Bruker, Raises Price Target to $60

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $44 to $60.

Benzinga Newsdesk